Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: Detailed characterization of the first strain with high-level resistance to ceftriaxone

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 7, 2011, Pages 3538-3545

  Ohnishi, Makoto ^a   Golparian, Daniel ^b   Shimuta, Ken ^a   Saika, Takeshi ^c   Hoshina, Shinji ^d   Iwasaku, Kazuhiro ^e   Nakayama, Shu Ichi ^a   Kitawaki, Jo ^e   Unemo, Magnus ^b  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c LSI MEDIENCE CORPORATION   (Japan)

^d Hoshina Clinic   (Japan)

^e KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZTREONAM; BACTERIAL PROTEIN; CEFEPIME; CEFIXIME; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ERTAPENEM; IMIPENEM; LEVOFLOXACIN; MACROLIDE; MECILLINAM; MEROPENEM; MTRR PROTEIN; NITROFURANTOIN; PENA PROTEIN; PENB PROTEIN; PENICILLIN G; PILQ PROTEIN; PIPERACILLIN PLUS TAZOBACTAM; PONA PROTEIN; PORB PROTEIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM TRANSFORMATION; GENE FREQUENCY; GENE SEQUENCE; GONORRHEA; MINIMUM INHIBITORY CONCENTRATION; MOSAICISM; NEISSERIA GONORRHOEAE; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; SEROTYPE;

ANIMALS; CEFTRIAXONE; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GONORRHEA; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; NEISSERIA GONORRHOEAE;

EID: 79959189164     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00325-11     Document Type: Article

References (50)

1. Ameyama, S., et al. 2002. Mosaic-like structure of penicillin-binding protein 2 gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime. Antimicrob. Agents Chemother. 46:3744-3749.
2. Bachmann, L. H., R. A. Desmond, J. Stephens, A. Hughes, and E. W. Hook III. 2002. Duration of persistence of gonococcal DNA detected by ligase chain reaction in men and women following recommended therapy for uncomplicated gonorrhea. J. Clin. Microbiol. 40:3596-3601.
3. Barry, P. M., and J. D. Klausner. 2009. The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert Opin. Pharmacother. 10:555-577.
4. Boslego, J. W., et al. 1987. Effect of spectinomycin use on the prevalence of spectinomycin-resistant and penicillinase-producing Neisseria gonorrhoeae. N. Engl. J. Med. 317:272-278.
5. CDS Reference Laboratory. Accession date, 30 April 2011. The CDS Antibiotic Susceptibility Test Website. CDS Reference Laboratory, Department of Microbiology, South Eastern Area Laboratory Services (SEALS), The Prince of Wales Hospital, Randwick, NSW, Australia. http://web.med.unsw.edu.au/cdstest.
6. Chisholm, S. A., et al. 2010. Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink? J. Antimicrob. Chemother. 65:2141-2148.
7. Chisholm, S. A., et al. 2011. An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in Europe. J. Antimicrob. Chemother. 66:592-595.
8. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing, 19th informational supplement. CLSI document M100-S19. CLSI, Wayne, PA.
9. Deguchi, T., et al. 2003. Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval. J. Infect. Chemother. 9:35-39.
10. Goire, N., M. D. Nissen, G. M. LeCornec, T. P. Sloots, and D. M. Whiley. 2008. A duplex Neisseria gonorrhoeae real-time polymerase chain reaction assay targeting the gonococcal porA pseudogene and multicopy opa genes. Diagn. Microbiol. Infect. Dis. 61:6-12.
11. Golparian, D., B. Hellmark, H. Fredlund, and M. Unemo. 2010. Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden. Sex. Transm. Infect. 86:454-460.
12. Hagman, K. E., et al. 1995. Resistance of Neisseria gonorrhoeae to antimicrobial hydrophobic agents is modulated by the mtrRCDE efflux system. Microbiology 141:611-622.
13. Hjelmevoll, S. O., et al. 2006. A fast real-time polymerase chain reaction method for sensitive and specific detection of the Neisseria gonorrhoeae porA pseudogene. J. Mol. Diagn. 8:574-581.
14. Ito, M., et al. 2005. Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in central Japan. Antimicrob. Agents Chemother. 49:137-143.
15. Kirkcaldy, R. D., R. C. Ballard, and D. Dowell. 2011. Gonococcal resistance: are cephalosporins next? Curr. Infect. Dis. Rep. 13:196-204.
16. Lee, S. G., et al. 2010. Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone. J. Antimicrob. Chemother. 65:669-675.
17. Lewis, D. A. 2010. The gonococcus fights back: is this time a knock out? Sex. Transm. Infect. 86:415-421.
18. Lindberg, R., H. Fredlund, R. Nicholas, and M. Unemo. 2007. Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA. Antimicrob. Agents Chemother. 51:2117-2122.
19. Livermore, D. M., et al. 2004. Activity of ertapenem against Neisseria gonorrhoeae. J. Antimicrob. Chemother. 54:280-281.
20. Marshall, S. A., et al. 1995. Comparative antimicrobial activity of piperacillin-tazobactam tested against more than 5000 recent clinical isolates from five medical centers. A reevaluation after five years. Diagn. Microbiol. Infect. Dis. 21:153-168.
21. Muratani, T., et al. 2001. Outbreak of cefozopran (penicillin, oral cephems, and aztreonam)-resistant Neisseria gonorrhoeae in Japan. Antimicrob. Agents Chemother. 45:3603-3606.
22. Newman, L. M., J. S. Moran, and K. A. Workowski. 2007. Update on the management of gonorrhea in adults in the United States. Clin. Infect. Dis. 44(Suppl. 3):S84-S101.
23. Ohnishi, M., et al. 2011. Ceftriaxone-resistant Neisseria gonorrhoeae, Japan. Emerg. Infect. Dis. 17:148-149.
24. Ohnishi, M., et al. 2010. Spreading of a chromosomal cefixime-resistant penA gene among different Neisseria gonorrhoeae lineages. Antimicrob. Agents Chemother. 54:1060-1067.
25. Olesky, M., M. Hobbs, and R. A. Nicholas. 2002. Identification and analysis of amino acid mutations in porin IB that mediate intermediate-level resistance to penicillin and tetracycline in Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 46:2811-2820.
26. Olesky, M., S. Zhao, R. L. Rosenberg, and R. A. Nicholas. 2006. Porin-mediated antibiotic resistance in Neisseria gonorrhoeae: ion, solute, and antibiotic permeation through PIB proteins with penB mutations. J. Bacteriol. 188:2300-2308.
27. Osaka, K., et al. 2008. Analysis of amino acid sequences of penicillin-binding protein 2 in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime and ceftriaxone. J. Infect. Chemother. 14:195-203.
28. Pandori, M., et al. 2009. Mosaic penicillin-binding protein 2 in Neisseria gonorrhoeae isolates collected in 2008 in San Francisco, California. Antimicrob. Agents Chemother. 53:4032-4034.
29. Ropp, P. A., M. Hu, M. Olesky, and R. A. Nicholas. 2002. Mutations in ponA, the gene encoding penicillin-binding protein 1, and a novel locus, penC, are required for high-level chromosomally mediated penicillin resistance in Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 46:769-777.
30. Shafer, W. M., and J. P. Folster. 2006. Towards an understanding of chromosomally mediated penicillin resistance in Neisseria gonorrhoeae: evidence for a porin-efflux pump collaboration. J. Bacteriol. 188:2297-2299.
31. Simpson, M. L., M. Y. Khan, Y. Siddiqui, R. P. Gruninger, and D. I. Wigren. 1982. Comparison of piperacillin and penicillin in the treatment of uncomplicated gonorrhea. Antimicrob. Agents Chemother. 21:727-729.
32. Takahata, S., N. Senju, Y. Osaki, T. Yoshida, and T. Ida. 2006. Amino acid substitutions in mosaic penicillin-binding protein 2 associated with reduced susceptibility to cefixime in clinical isolates of Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 50:3638-3645.
33. Tanaka, M., et al. 2006. Analysis of mutations within multiple genes associated with resistance in a clinical isolate of Neisseria gonorrhoeae with reduced ceftriaxone susceptibility that shows a multidrug-resistant phenotype. Int. J. Antimicrob. Agents 27:20-26.
34. Tapsall, J. W. 2001. Antimicrobial resistance in Neisseria gonorrhoeae. WHO/CDS/CSR/DRS/2001.3. World Health Organization. Geneva 2001. http://www.who.int/entity/drugresistance/Antimicrobial-resistance-in-Neisseria- gonorrhoeae.pdf.
35. Tapsall, J. W. 2004. Antimicrobial testing and applications in the pathogenic Neisseria, p. 175-188. In J. Merlino (ed.), Antimicrobial susceptibility testing: methods and practices with an Australian perspective. Australian Society for Microbiology, Sydney, Australia.
36. Tapsall, J. W., F. Ndowa, D. A. Lewis, and M. Unemo. 2009. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Exp. Rev. Anti Infect. Ther. 7:821-834.
37. Thirumoorthy, T., K. B. Lim, C. T. Lee, and E. H. Sng. 1987. Single dose piperacillin in treating uncomplicated gonococcal urethritis in men. Genitourin. Med. 63:309-311.
38. Tomberg, J., M. Unemo, C. Davies, and R. A. Nicholas. 2010. Molecular and structural analysis of mosaic variants of penicillin-binding protein 2 conferring decreased susceptibility to expanded-spectrum cephalosporins in Neisseria gonorrhoeae: role of epistatic mutations. Biochemistry 49:8062-8070.
39. Unemo, M., et al. 2007. Molecular characterization of Neisseria gonorrhoeae identifies transmission and resistance of one ciprofloxacin- resistant strain. APMIS 115:231-241.
40. Unemo, M., D. Golparian, G. Syversen, D. F. Vestrheim, and H. Moi. 2010. Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. Euro. Surveill. 15(47):pii=19721.
41. Unemo, M., O. Fasth, H. Fredlund, A. Limnios, and J. W. Tapsall. 2009. Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J. Antimicrob. Chemother. 63:1142-1151.
42. Unemo, M., P. Olcén, T. Berglund, J. Albert, and H. Fredlund. 2002. Molecular epidemiology of Neisseria gonorrhoeae: sequence analysis of the porB gene confirms presence of two circulating strains. J. Clin. Microbiol. 40:3741-3749.
43. Veal, W. L., R. A. Nicholas, and W. M. Shafer. 2002. Overexpression of the MtrC-MtrD-MtrE efflux pump due to an mtrR mutation is required for chromosomally mediated penicillin resistance in Neisseria gonorrhoeae. J. Bacteriol. 184:5619-5624.
44. Whiley, D. M., A. Limnios, S. Ray, T. P. Sloots, and J. W. Tapsall. 2007. Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxone. Antimicrob. Agents Chemother. 51:3111-3116.
45. Whiley, D. M., et al. 2010. Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains. J. Antimicrob. Chemother. 65:2543-2547.
46. World Health Organization. Accession date, 30 April 2011. Gonorrhoea - incidence rate (per 100,000 population). Centralized Information System for Infectious Diseases (CISID) Website: Sexually transmitted infections (STI). WHO Regional Office for Europe, Copenhagen, Denmark. http://data.euro.who.int/cisid.
47. Yokoi, S., et al. 2007. Threat to cefixime treatment of gonorrhea. Emerg. Infect. Dis. 13:1275-1277.
48. Zarantonelli, L., G. Borthagaray, E. H. Lee, and W. M. Shafer. 1999. Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations. Antimicrob. Agents Chemother. 43:2468-2472.
49. Zhao, S., D. M. Tobiason, M. Hu, H. S. Seifert, and R. A. Nicholas. 2005. The penC mutation conferring antibiotic resistance in Neisseria gonorrhoeae arises from a mutation in the PilQ secretin that interferes with multimer stability. Mol. Microbiol. 57:1238-1251.
50. Zhao, S., et al. 2009. Genetics of chromosomally mediated intermediate resistance to ceftriaxone and cefixime in Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 53:3744-3751.